Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N6YV
|
||||
Former ID |
DIB012782
|
||||
Drug Name |
Cenestin
|
||||
Synonyms |
Synthetic conjugated estrogens-A, Barr; Synthetic conjugated estrogens-A, Duramed
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Menopause symptoms [ICD10:N95.0] | Approved | [551871] | ||
Company |
Duramed Pharmaceuticals Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C18H19NaO5S
|
||||
Canonical SMILES |
[Na+].O=S(=O)(Oc1cc2c([C@@H]3[C@H]([C@H]4[C@](CC3)(C(=O<br />)CC4)C)CC2)cc1)[O-].[Na+].O=S(=O)(Oc1cc2c([C@@H]3C(=CC2<br />)[C@H]2[C@](CC3)(C(=O)CC2)C)cc1)[O-]
|
||||
CAS Number |
CAS 12126-59-9
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Estrogen receptor | Target Info | Agonist | [526290], [551871] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Signaling events mediated by HDAC Class II | |||||
Plasma membrane estrogen receptor signaling | |||||
LKB1 signaling events | |||||
Regulation of Telomerase | |||||
ATF-2 transcription factor network | |||||
AP-1 transcription factor network | |||||
FOXM1 transcription factor network | |||||
Validated nuclear estrogen receptor alpha network | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
FOXA1 transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.